- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Michelle Riederer, MD
Psychiatry • Child and Adolescent Psychiatry- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Michelle Riederer, MD
Psychiatry • Child and Adolescent Psychiatry- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology
- Psychiatry, American Board of Psychiatry and Neurology
Fellowship
- Child/Adolescent Psychiatry, Stanford University Medical Center - Fellowships
Residency
- Psychiatry, New York University School of Medicine
Degree
- MD, ICAHN School of Medicine at Mount Sinai
My expertise
Specialties
- Psychiatry
- Child and Adolescent Psychiatry
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%223437%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223437%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.